| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
2024 Outlook1
Tenet's Outlook for full year 2024 (consolidated and by segment) and second quarter 2024 follows. This outlook reflects the completion of the sale of three Coastal South Carolina hospitals on January 31, 2024 and the completion of the sale of six California hospitals on March 31, 2024.
|
CONSOLIDATED ($ in millions, except per share amounts) |
FY 2024 Outlook |
Second Quarter |
|
Net operating revenues |
$20,000 to $20,400 |
$4,900 to $5,100 |
|
Net income from continuing operations available to Tenet common stockholders |
$2,622 to $2,762 |
$150 to $195 |
|
Adjusted EBITDA |
$3,500 to $3,700 |
$835 to $885 |
|
Adjusted EBITDA margin |
17.5% to 18.1% |
17.0% to 17.4% |
|
Diluted income per common share from continuing operations |
$25.96 to $27.35 |
$1.49 to $1.93 |
|
Adjusted net income from continuing operations |
$845 to $950 |
$160 to $200 |
|
Adjusted diluted earnings per share from continuing operations |
$8.37 to $9.41 |
$1.58 to $1.98 |
|
Equity in earnings of unconsolidated affiliates |
$220 to $230 |
$50 to $60 |
|
Depreciation and amortization |
$830 to $860 |
$210 to $220 |
|
Interest expense |
$825 to $835 |
$220 to $230 |
|
Income tax expense5 |
$945 to $995 |
$80 to $95 |
|
Net income available to NCI |
$750 to $800 |
$160 to $170 |
|
Weighted average diluted common shares |
~101 million |
~101 million |
|
NCI cash distributions |
$665 to $715 |
|
|
Net cash provided by operating activities6 |
$1,725 to $2,075 |
|
|
Adjusted net cash provided by operating activities6 |
$1,825 to $2,125 |
|
|
Capital expenditures |
$775 to $875 |
|
|
Free cash flow – continuing operations6 |
$950 to $1,200 |
|
|
Adjusted free cash flow – continuing operations6 |
$1,050 to $1,250 |
Posted In: THC
